Investigating the effect of visfatin on ERalpha phosphorylation (Ser118 and Ser167) and ERE-dependent transcriptional activity.

EXCLI J 2018 4;17:516-525. Epub 2018 Jun 4.

Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Obesity is associated with higher postmenopausal breast cancer incidence. Visfatin level alteration is one of the mechanisms by which obesity promotes cancer. Ligand-independent activation of estrogen receptor alpha (ERα) is also associated with carcinogenesis. The activity of ERα is modulated through phosphorylation on multiple sites by a number of protein kinases. Here we investigated the effect of visfatin as a novel adipocytokine on the phosphorylation and activity of ERα in MCF-7 breast cancer cells. We showed that exogenous administration of visfatin significantly increased the phosphorylation of ERα at serine 118 (Ser118) and 167 (Ser167) residues. Visfatin-induced Ser118 phosphorylation was diminished after treatment of cells with U0126 (MEK1/2 inhibitor). Furthermore, our results showed that visfatin-induced Ser167 phosphorylation is mediated through both MAPK and PI3K/Akt signaling pathways. Inhibition of the enzymatic activity of visfatin by FK866 had no effect on phosphorylation of ERα. We also showed that visfatin enhanced the estrogen response element (ERE)-dependent activity of ER in the presence of 17-β estradiol (E2). Additional study on T47D cells showed that visfatin also increased Ser118 and Ser167 phosphorylation of ERα and enhanced ERE-dependent activity in the presence of E2 in these cells.

Download full-text PDF

Source
http://dx.doi.org/10.17179/excli2018-1299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046625PMC
June 2018
4 Reads
0.857 Impact Factor

Publication Analysis

Top Keywords

phosphorylation erα
12
ere-dependent activity
8
activity presence
8
activity erα
8
ser118 ser167
8
breast cancer
8
ser167 phosphorylation
8
visfatin increased
8
phosphorylation
8
visfatin
6
erα
6
activity
6
ser167 residues
4
167 ser167
4
ser118 167
4
investigated visfatin
4
residues visfatin-induced
4
visfatin-induced ser118
4
treatment cells
4
cells u0126
4

Similar Publications